These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16019767)

  • 1. T1 G1 urinary bladder carcinoma: fact or fiction?
    Mikulowski P; Hellsten S
    Scand J Urol Nephrol; 2005; 39(2):135-7. PubMed ID: 16019767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of very large superficial bladder tumours: a 10-year experience.
    Gupta SK; Parr NJ
    Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is microstaging of early invasive cancer of the urinary bladder possible or useful?
    Platz CE; Cohen MB; Jones MP; Olson DB; Lynch CF
    Mod Pathol; 1996 Nov; 9(11):1035-9. PubMed ID: 8933512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001.
    Gårdmark T; Bladström A; Hellsten S; Malmström PU;
    Scand J Urol Nephrol; 2006; 40(4):276-82. PubMed ID: 16916767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stage T1 tumor of the bladder. From research to prognosis].
    Albert P; Leremboure H; Hernandez F; Coulange C; Rampal M
    Ann Urol (Paris); 1988; 22(4):255-61. PubMed ID: 3056232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours.
    Olsson H; Hultman P; Rosell J; Jahnson S
    Scand J Urol; 2013 Jun; 47(3):188-95. PubMed ID: 22954205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
    Guney S; Guney N; Canogullari Z; Ergenekon E
    Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
    Shen YJ; Ye DW; Yao XD; Trink B; Zhou XY; Zhang SL; Dai B; Zhang HL; Zhu Y; Guo Z; Wu G; Nagpal J
    BJU Int; 2008 Jan; 101(1):113-9. PubMed ID: 17941920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling.
    Maruniak NA; Takezawa K; Murphy WM
    J Urol; 2002 Jun; 167(6):2404-7. PubMed ID: 11992046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
    Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
    BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bladder tumor in young patients: a series of 26 cases. Comparison with a review of the literature].
    Blanchard JM; Graziana JP; Bonnal JL; Biserte J; Mauroy B
    Prog Urol; 2003 Apr; 13(2):227-33. PubMed ID: 12765056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coding criteria of bladder cancer: effects on estimating survival.
    Patriarca S; Gafà L; Ferretti S; Vitarelli S; Cesaraccio R; Crocetti E; Ferrante MC; Rollo P; Tagliabue G
    Epidemiol Prev; 2001; 25(3 Suppl):42-7. PubMed ID: 11695203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance.
    Lopez-Beltran A; Cheng L
    Pathology; 2003 Dec; 35(6):484-91. PubMed ID: 14660098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.